Saqib Islam

This profile gathers the share dealings of Saqib Islam across 3 companies, led by SpringWorks Therapeutics, Inc., Alexion Pharmaceuticals Inc and Passage BIO, Inc. Over a trading history stretching from 4 February 2016 to 1 July 2025, the count stands at 57 filings.

In open-market terms, that means 1 purchase worth €81k on one side and 36 sales worth €28.2M on the other. On balance, insiders were net sellers of €28.1M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 19 share grants. Since January 2025: no purchases and 9 sales on the market.

Most recently, on 2 July 2025, the filings show a transaction in SpringWorks Therapeutics, Inc. The latest purchase dates back some time: it was published 2,425 days ago, on 3 March 2020. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.